Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

LifeStance Health (LFST) Accumulated Depreciation & Amortization (2020 - 2025)

LifeStance Health (LFST) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $41.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 2.32% to $41.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $41.6 million, a 2.32% increase, with the full-year FY2025 number at $41.6 million, up 2.32% from a year prior.
  • Accumulated Depreciation & Amortization was $41.6 million for Q4 2025 at LifeStance Health, up from $10.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $41.6 million in Q4 2025 to a low of $2.6 million in Q1 2021.
  • A 5-year average of $17.2 million and a median of $11.4 million in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 644.3% in 2021, then crashed 66.15% in 2025.
  • LifeStance Health's Accumulated Depreciation & Amortization stood at $15.1 million in 2021, then surged by 91.59% to $28.9 million in 2022, then grew by 29.23% to $37.4 million in 2023, then rose by 8.84% to $40.7 million in 2024, then increased by 2.32% to $41.6 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Accumulated Depreciation & Amortization are $41.6 million (Q4 2025), $10.3 million (Q3 2025), and $20.9 million (Q2 2025).